These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32354656)

  • 1. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.
    Krepline AN; Geurts JL; Akinola I; Christians KK; Clarke CN; George B; Ritch PS; Khan AH; Hall WA; Erickson BA; Griffin MO; Evans DB; Tsai S
    HPB (Oxford); 2020 Dec; 22(12):1745-1752. PubMed ID: 32354656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
    Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
    Uson PLS; Samadder NJ; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Kunze K; Golafshar M; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T
    Clin Transl Gastroenterol; 2021 Oct; 12(10):e00414. PubMed ID: 34620795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
    Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK
    Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.
    Ramsey ML; Tomlinson J; Pearlman R; Abushahin L; Aeilts A; Chen HZ; Chen Y; Compton A; Elkhatib R; Geiger L; Hays J; Jeter J; Jin N; Malalur P; Roychowdhury S; Ruple J; Prebish J; Stanich PP; Hampel H
    Fam Cancer; 2023 Jan; 22(1):91-97. PubMed ID: 35713757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers.
    Ando Y; Dbouk M; Yoshida T; Abou Diwan E; Saba H; Dbouk A; Yoshida K; Roberts NJ; Klein AP; Burkhart R; He J; Hruban RH; Goggins M
    JCO Precis Oncol; 2024 May; 8():e2400101. PubMed ID: 38781545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
    Cragun D; Weidner A; Tezak A; Clouse K; Pal T
    Breast Cancer Res Treat; 2020 Jul; 182(2):421-428. PubMed ID: 32445176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
    Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
    BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
    Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
    Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
    Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
    Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.
    Hoffman TL; Kershberg H; Goff J; Holmquist KJ; Haque R; Alvarado M
    Fam Cancer; 2023 Apr; 22(2):225-235. PubMed ID: 36261688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
    Mohindroo C; Baydogan S; Agarwal P; Wright RD; Prakash LR; Mork ME; Klein AP; Laheru DA; Maxwell JE; Katz MHG; Dasari A; Kim MP; He J; McAllister F; De Jesus-Acosta A
    Cancer Prev Res (Phila); 2024 Jul; 17(7):335-342. PubMed ID: 38662083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variants in Patients With a Family History of Pancreatic Cancer: Impact of Multigene Panel Testing.
    Zhu H; Welinsky S; Soper ER; Brown KL; Abul-Husn NS; Lucas AL
    Pancreas; 2021 Apr; 50(4):602-606. PubMed ID: 33939675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
    Sandoval RL; Leite ACR; Barbalho DM; Assad DX; Barroso R; Polidorio N; Dos Anjos CH; de Miranda AD; Ferreira ACSM; Fernandes GDS; Achatz MI
    PLoS One; 2021; 16(2):e0247363. PubMed ID: 33606809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary pancreatic cancer.
    Abe K; Kitago M; Kitagawa Y; Hirasawa A
    Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
    Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pathogenic germline variants identified in mesothelioma.
    Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
    Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.